Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹13,639Cr
Rev Gr TTM
Revenue Growth TTM
23.30%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

INOXINDIA
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | 19.2 | 17.5 | -3.9 | 19.0 | 14.8 | 33.6 | 14.6 | 16.9 | 28.4 |
| 195 | 237 | 199 | 224 | 223 | 226 | 243 | 265 | 288 | 263 | 280 | 335 |
Operating Profit Operating ProfitCr |
| 17.0 | 23.2 | 22.8 | 22.9 | 19.3 | 23.7 | 20.8 | 20.7 | 22.0 | 22.4 | 21.8 | 21.8 |
Other Income Other IncomeCr | 6 | 8 | 7 | 5 | 11 | 5 | 13 | 16 | 13 | 13 | 13 | -1 |
Interest Expense Interest ExpenseCr | 2 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 1 | 1 | 2 | 3 |
Depreciation DepreciationCr | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 7 | 8 | 8 | 9 |
| 41 | 76 | 60 | 64 | 58 | 68 | 69 | 76 | 86 | 81 | 81 | 80 |
| 10 | 19 | 14 | 15 | 14 | 15 | 19 | 18 | 21 | 19 | 20 | 20 |
|
Growth YoY PAT Growth YoY% | | | | 19.4 | 44.0 | -7.8 | 7.0 | 20.2 | 48.6 | 16.1 | 22.9 | 4.0 |
| 13.0 | 18.5 | 17.9 | 16.7 | 15.9 | 17.8 | 16.1 | 17.5 | 17.7 | 18.0 | 17.0 | 14.2 |
| 3.4 | 6.3 | 5.1 | 5.3 | 4.9 | 5.8 | 5.5 | 6.4 | 7.2 | 6.7 | 6.7 | 6.7 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 2.2 | 41.8 | 0.9 | -8.5 | 31.8 | 23.4 | 17.3 | 15.2 | 14.5 |
| 433 | 349 | 500 | 516 | 459 | 615 | 762 | 883 | 1,021 | 1,167 |
Operating Profit Operating ProfitCr |
| 2.4 | 23.0 | 22.3 | 20.5 | 22.6 | 21.4 | 21.2 | 22.1 | 21.8 | 22.0 |
Other Income Other IncomeCr | 16 | 13 | 10 | 43 | 15 | 21 | 20 | 31 | 48 | 37 |
Interest Expense Interest ExpenseCr | 41 | 28 | 27 | 26 | 7 | 2 | 4 | 6 | 9 | 7 |
Depreciation DepreciationCr | 23 | 9 | 9 | 12 | 12 | 12 | 14 | 18 | 25 | 32 |
| -38 | 79 | 117 | 138 | 131 | 174 | 207 | 258 | 299 | 328 |
| 0 | 1 | -59 | 46 | 35 | 44 | 52 | 62 | 73 | 80 |
|
| | 307.3 | 126.0 | -47.7 | 4.5 | 35.8 | 18.6 | 26.7 | 15.3 | 9.8 |
| -8.4 | 17.1 | 27.3 | 14.2 | 16.2 | 16.7 | 16.0 | 17.3 | 17.3 | 16.6 |
| -41.4 | 1.8 | 212.4 | 107.2 | 10.6 | 14.4 | 17.1 | 21.6 | 24.9 | 27.3 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 9 | 9 | 9 | 9 | 9 | 18 | 18 | 18 | 18 | 18 |
| -14 | -23 | 176 | 272 | 362 | 484 | 531 | 631 | 856 | 962 |
Current Liabilities Current LiabilitiesCr | 587 | 400 | 443 | 325 | 295 | 373 | 570 | 543 | 753 | 886 |
Non Current Liabilities Non Current LiabilitiesCr | 219 | 348 | 72 | 24 | 21 | 22 | 28 | 31 | 29 | 29 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 539 | 367 | 480 | 505 | 521 | 743 | 962 | 936 | 1,265 | 1,472 |
Non Current Assets Non Current AssetsCr | 286 | 400 | 244 | 124 | 166 | 154 | 185 | 287 | 390 | 412 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 54 | 83 | 85 | 188 | 231 | 97 | 177 | 122 | 122 |
Investing Cash Flow Investing Cash FlowCr | 5 | 88 | 143 | -5 | -148 | -75 | -12 | -25 | -139 |
Financing Cash Flow Financing Cash FlowCr | -55 | -169 | -186 | -168 | -96 | -26 | -154 | -103 | 17 |
|
Free Cash Flow Free Cash FlowCr | 49 | 79 | 70 | 175 | 225 | 53 | 132 | 32 | -3 |
| -144.7 | 106.9 | 48.3 | 204.5 | 240.0 | 74.4 | 114.2 | 62.5 | 54.0 |
CFO To EBITDA CFO To EBITDA% | 503.8 | 79.8 | 59.2 | 141.6 | 171.5 | 57.9 | 86.5 | 48.9 | 42.8 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | | 0 | 0 | 0 | 0 | 0 | 11,073 | 9,073 |
Price To Earnings Price To Earnings | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 56.5 | 40.1 |
Price To Sales Price To Sales | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.8 | 7.0 |
Price To Book Price To Book | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 17.1 | 10.4 |
| 47.3 | | 1.3 | 0.3 | -1.0 | 0.3 | -0.3 | 44.3 | 31.9 |
Profitability Ratios Profitability Ratios |
| 55.6 | 60.2 | 62.7 | 56.3 | 58.3 | 56.9 | 55.2 | 55.5 | 55.8 |
| 2.4 | 23.0 | 22.3 | 20.5 | 22.6 | 21.4 | 21.2 | 22.1 | 21.8 |
| -8.4 | 17.1 | 27.3 | 14.2 | 16.2 | 16.7 | 16.0 | 17.3 | 17.3 |
| 0.7 | 48.0 | 32.8 | 43.9 | 31.4 | 31.7 | 37.7 | 39.6 | 33.5 |
| 712.5 | -541.3 | 95.1 | 32.7 | 25.9 | 26.0 | 28.2 | 30.2 | 25.9 |
| -4.5 | 10.1 | 24.3 | 14.6 | 14.0 | 14.6 | 13.5 | 16.0 | 13.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
#### **Overview**
Inox India Limited (INOXCVA) is one of India’s largest and most technologically advanced manufacturers of **cryogenic storage, regasification, and distribution systems**, serving global markets across **industrial gases, LNG, hydrogen, and cryo-scientific applications**. With over 30 years of experience, the company has evolved into a global player with operations in **India, Brazil, and Europe**, and a presence in over **100 countries**, supported by after-sales networks in 25+ nations. As of FY25, INOXCVA is a **debt-free, net cash surplus** company with strong financials, robust innovation capabilities, and leadership in high-barrier engineering sectors.
---
#### **Core Business Segments**
INOXCVA operates across three key verticals:
1. **Industrial Gas Solutions (IGS)**
2. **LNG & Clean Energy Infrastructure**
3. **Cryo Scientific Division (CSD)**
Over the past two years, **exports have accounted for over 50% of total revenue**, demonstrating strong international competitiveness and diversified client base.
---
#### **1. Cryo Scientific Division: Global Research & Fusion Leadership**
- **ITER Project (France):** INOXCVA secured a **major order worth INR 145 crores** for the **Cryostat Thermal Shield**—a one-time project arising from prior failures, but a testament to INOXCVA’s reliability and technical superiority.
- The project spans **two years**, with **90% in-house fabrication** and 10% on-site assembly in France via a 25-member dedicated team.
- This reinforces INOXCVA’s status as one of the **few Indian companies contributing to the International Thermonuclear Experimental Reactor (ITER)**.
- **Scientific Diversification:** Secured repeat and new orders from **CERN (Switzerland), FAIR (Germany), and Wrocław University of Science and Technology (Poland)**.
- **Breakthrough in Medical Tech:**
- Developed **India’s first indigenous 1.5T MRI magnet cryostat** with SAMEER and MeitY.
- Installed India’s **first indigenously developed MRI machine at AIIMS Delhi**, reducing dependence on imports.
- **High-Precision Engineering:** Executing complex repairs for **Vacuum Vessel Thermal Shield (VVTS) panels** using 5-axis machining and welding at its Savli facility.
---
#### **2. LNG & Clean Energy Infrastructure: Scaling for Global Demand**
- **Bahamas Mega Project:**
- Awarded the **largest order in company history**—a **turnkey contract for a 15,000 m³ mini-LNG terminal** in Nassau to supply **72 MW combined-cycle power plant** for shore power to cruise ships.
- The project will feature the **world’s largest shop-built, double-walled, vacuum-insulated cryogenic tanks** (10 x 1,500 m³), setting a global benchmark in modular LNG infrastructure.
- **India’s LNG Ecosystem Growth:**
- Supplies **LNG fuel tanks to all four major Indian OEMs**; over **1,500 Gen 2 tanks ordered** for FY26 delivery.
- Partnered with **MSRTC** for diesel-to-LNG bus conversions; systems installed in Gujarat.
- Supplies **LNG fuel systems for Indian Railways**, with units operational in Gujarat.
- **Global Expansion:**
- Commissioned mini-LNG terminals in **Antigua, Scotland, and The Bahamas**.
- Exported record **560 m³ marine LNG tanks** to a European shipyard for a Japanese cruise vessel.
- Secured LNG semi-trailer orders from the **USA, Taiwan, and South America**.
---
#### **3. Industrial Gas & High-Purity Solutions: Innovation in Semiconductors**
- **Q1 FY26 Revenue: INR 352 Crores (+16.7% YoY)** – driven primarily by the **Industrial Gas segment**.
- **Ultra-High Purity Ammonia Tanks:**
- Delivered **India’s first ultra-high purity ammonia ISO containers** (certified by DNV, compliant with IMO/ISO) for **semiconductor and solar panel manufacturing**.
- Design pressure: **19.69 bar**, cleanliness level: 7N grade.
- Additional **10 units under construction**; INOXCVA is the **only domestic manufacturer** of such high-spec tanks.
- **Export Breakthrough:** Secured first order from **Australia** for oxygen, nitrogen, and CO₂ IMO containers—direct competition with Chinese vendors.
- **Liquid Hydrogen Leadership:**
- Supplied **first 2,000-liter liquid hydrogen tank** to a New Zealand customer.
- Installed **liquid H₂ tanks in South Korea**; delivered to DRDO for **submarine AIP systems**.
- Developed **LSI (MLS1) insulation tanks** for space and mobility applications.
---
#### **4. Beverage Keg Division: Strategic Global Footprint**
- **Savli Plant Performance:**
- Generated **INR 200 crores in revenue in FY25**, with a **target of INR 300–350 crores in FY26**.
- Installed capacity: **300,000 kegs/year**, with **only ~50,000 produced in FY25**.
- Scaling up capacity and manpower; over **150 tanks currently under construction**.
- **Global Approvals:**
- Secured **global supply approvals from Heineken and AB InBev**.
- Pending Carlsberg audit expected to open a significant pipeline.
- Achieved **FSSC 22000 certification**—**first in Asia** for keg manufacturing.
- **New Market Access:**
- Appointed **new distributors in the U.K., Germany, and the U.S.**
- Strong RFQs: Over **150,000 kegs requested** from India, U.S., Europe, and Australia.
- **Partnerships:** Collaborating with **Supermonte (Italy)** to supply premium returnable stainless steel kegs from dual hubs.
---
#### **5. Green Transition & New Product Innovation**
- **CO₂ Battery Launch:**
- Released **India’s first CO₂ battery**—a **scalable, sustainable alternative to lithium-ion**, with superior lifespan and safety.
- Secured an **order from an Italian client for a project in India**, despite rising import tariffs.
- **Ammonia Transport Growth:**
- Anticipates **hundreds of orders** for **ammonia ISO containers** as green ammonia demand rises for fertilizers and semiconductors.
- Delivered **first 2,000 m³ ammonia tank to a Middle East customer**.
- **Liquid Air Energy Storage (LAES):**
- Signed **landmark contract with Highview Power (UK)** to supply **five 690-kL vertical cryogenic tanks** for the **world’s largest commercial-scale LAES facility** in Manchester.
- Marks strategic entry into **long-duration energy storage (LDES)**.
---
#### **6. Financial & Operational Strength**
- **Order Backlog & Revenue:**
- **Order Book (FY25): INR 1,359 Crores**
- **Exports Contribution:** ~63% of backlog (May 2025 data)
- **Q1 FY26 Revenue: INR 352 Crores** (+16.7% YoY)
- FY24 Revenue: ~INR 1,200 crores (estimate); **3-Year CAGR: 24%**
- **Profitability & Efficiency:**
- **EBITDA Margin (FY24): 24%**
- **PAT Margin (FY24): 17%**
- **RoCE: 39%**, **ROE: 30%** – indicating exceptional capital efficiency.
- **Debt & Cashflow:**
- **Net cash surplus; debt-free** – funded all recent capex (e.g., INR 100 crore Savli plant) via **internal accruals**.
- **Management Guidance:**
- Targets **18–20% revenue growth** and **EBITDA growth ahead of revenue** in FY26, supported by **fixed-margin quoting** and strong order execution.
---
#### **7. Manufacturing & R&D Capabilities**
- **Four Manufacturing Facilities in India:** Kalol, Kandla (SEZ), Silvassa, and **Savli (Gujarat)** – the newest and most advanced.
- **Savli Expansion:** Investment of **INR 80 crores**; expected to add **INR 300–500 crores** in capacity over 1–2 years.
- **Engineering Powerhouse:** **400+ in-house engineers** focused on R&D, customization, and advanced modeling.
- **Patents & Innovation:**
- 3 recent patents for **LNG dispensing system**, **sliding spacer for cryogenic piping**, and **displacement decoupling**.
- Developed **IIT Bombay-BARC technology-based Helium Dewars** for MRI, research, and quantum computing.